Inventor
CALLENDRET BENOIT CHRISTOPHE STEPHAN
NL11 patents
⚠️ This page may combine multiple inventors who share the name “CALLENDRET BENOIT CHRISTOPHE STEPHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN VACCINES & PREVENTION BV
7 patentsUS10369214B2Aug 6, 2019
Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof
JANSSEN VACCINES & PREVENTION BV5 citations80
US11229695B2Jan 25, 2022
Method for the safe induction of immunity against RSV
JANSSEN VACCINES & PREVENTION BV8 citations79
US11896663B2Feb 13, 2024
Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins
JANSSEN VACCINES & PREVENTION BV0 citations59
US10973907B2Apr 13, 2021
Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens
JANSSEN VACCINES & PREVENTION BV0 citations59
US10925955B2Feb 23, 2021
Methods and compositions for inducing protective immunity against a Marburg virus infection
JANSSEN VACCINES & PREVENTION BV0 citations59
US10925956B2Feb 23, 2021
Methods and compositions for inducing protective immunity against a marburg virus infection
JANSSEN VACCINES & PREVENTION BV0 citations43
US11173204B2Nov 16, 2021
MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen
JANSSEN VACCINES & PREVENTION BV0 citations40
BAVARIAN NORDIC AS
4 patentsUS11918639B2Mar 5, 2024
Methods and compositions for inducing protective immunity against filovirus infection
BAVARIAN NORDIC AS0 citations59
US11173201B2Nov 16, 2021
Methods and compositions for inducing protective immunity against filovirus infection
BAVARIAN NORDIC AS0 citations59
US10561722B2Feb 18, 2020
Methods and compositions for enhancing immune responses
BAVARIAN NORDIC AS1 citations58
US10561721B2Feb 18, 2020
Methods and compositions for inducing protective immunity against filovirus infection
BAVARIAN NORDIC AS0 citations49